Author name: Dave Cundiff, MD, MPH, FASAM

Dr. Cundiff is board-certified in Addiction Medicine and in Public Health & General Preventive Medicine. He earned his MD at the University of Pennsylvania and his MPH at Johns Hopkins, and serves on the American Medical Association's Council on Science and Public Health. He is a Fellow of the American Society of Addiction Medicine and a national mentor on buprenorphine treatment through the Providers Clinical Support System. At Crestview, he leads the medical team, oversees medication management, and advises on clinical policy and practice.

a man shaking hands about treatment

House Bill 4002 in Oregon: A Turning Point for Drug Addiction and Behavioral Health Treatment

In a major shift in drug policy, Oregon passed House Bill 4002 (HB 4002) in 2024 to address the growing substance use crisis. Following mixed outcomes from Measure 110, this bill reintroduces criminal penalties for certain drug possession while emphasizing substance use treatment over traditional jail time.

House Bill 4002 in Oregon: A Turning Point for Drug Addiction and Behavioral Health Treatment Read More »

Accessibility Toolbar

Scroll to Top